Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
fMRI to Predict Ketamine Response in Neuropathic Pain
NCT02373449Completed
- Sponsor
- University Health Network
- Start
- Feb 2015
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ketamine in neuropathic pain, sponsored by University Health Network. Primary endpoint: Correlation between baseline (pre-infusion) fMRI patterns and pain relief (>50% pain reduction) at 1 month. Started Feb 2015; status: completed.
02
Drugs
ketamine
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT02373449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02373449.